代表性论著 1. Zheng SY, Chen CY, Qi WX, Cai G, Xu C, Cai R, Qian XF, Shen KW, Cao L(*), Chen JY(*). The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients. Breast. 2023 Apr:68:142-1482023 PMID: 36764019. 2. Hua X, Zhu QW, Zhang YN, Cao L, Wang MD, Gao YS, Chen JY. The prognostic significance of human ovarian aging-related signature in breast cancer after surgery: A multicohort study. Front Immunol. 2023 Mar 7;14:1139797. doi: 10.3389/fimmu.2023.1139797. PMID: 36960071; PMCID: PMC10027938. 3. Qian Zhu,#, Jinzhou Huang,#, Hongyang Huang, Huan Li, Peiqiang Yi, Jake A. Kloeber, Jian Yuan, Yuping Chen, Min Deng, Kuntian Luo, Ming Gao, Guijie Guo, Xinyi Tu, Ping Yin, Yong Zhang, Jun Su, Jiayi Chen,*, Zhenkun Lou,*,RNF19A-mediated Ubiquitination of BARD1 Prevents BRCA1/BARD1 Dependent Homologous Recombination,Nature Communications,2021 Nov 17;12(1):6653 4. Fei-Fei Xu(#), Sai-Fang Zheng(#), Cheng Xu, Gang Cai, Shu-Bei Wang, Wei- Xiang Qi, Chao-Fu Wang (*), Jia-Yi Chen (*) & Lu Cao (*) (2021) Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ, OncoImmunology, 10:1, 1875637 5. Peiqiang Yi, Huan Li, Yuehua Fang, Jun Su, Cheng Xu, Lu Cao, Min Li, Jiayi Chen. Administration of trastuzumab with heart irradiation induced acute cardiotoxicity in mice. Am J Cancer Res. 2020 Feb 1;10(2):536-544. PMID: 32195025; 6. Huan Li, Lu Cao, Pei-Qiang Yi, Cheng Xu, Jun Su, Pei-Zhan Chen, Min Li, Jia-Yi Chen. Pituitary adenylate cyclase-activating polypeptide ameliorates radiation-induced cardiac injury. Am J Transl Res 2019;11(10):6585-6599 7. Qian Zhu(#), Youlia M. Kirova, Lu Cao, Alexandre Arsene-Henry, Jiayi Chen(*). Cardiotoxicity associated with radiotherapy in breast cancer: A question-based review with current literatures. [J]. Cancer treatment reviews, 2018 July, 68: 9-15 8. Cao, Lu(#),Cai, Gang,Chang, Cai,Miao, Ai-Yu,Yu, Xiao-Li,Yang, Zhao-Zhi,Ma, Jin-Li,Zhang, Qian,Wu, Jiong,Guo, Xiao-Mao,Chen, Jia-Yi(*),Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.,Oncologist,2015,20(6):605-614。 9. Zhaozhi Yang, Jiayi Chen, Weigang Hu, Ziqiang Pan, Gang Cai, Xiaoli Yu, Xin Mei, Qian Zhang, T Liu, Xiaomao Guo. Planning the Breast Boost: How Accurately do Surgical Clips Represent the CT Seroma? Radiotherapy and Oncology, 2010) 97 (3) 530–534 主持基金项目 1、 国家自然科学基金面上项目,心肌源性微囊泡AEP调节巨噬细胞极化对放射性心脏损伤的保护作用机制研究(82373514),2024/01-2027/12,49万元,在研 2、 国家重点研发计划,MR-LINAC成像和放疗计划系统应用研究(独立子课题,2022YFC2404602),2022/11-2027/10,120万元,在研 3、 上海市科学技术委员会“科技创新行动计划”医学创新研究专项独立子课题,局部晚期及复发转移性宫颈癌治疗模式优化的临床及转化性研究(22Y31900103),2022/7-2025/6,20万元,在研 4、 国家重点研发计划,“基于同步加速器的质子放疗系统研发”子课题:质子放疗系统的临床应用技术研究及注册临床试验(2016YFC0105409),2016/7-2022/12,3192万,结题 5、 上海申康医院发展中心临床三年行动计划,乳腺癌术后区域淋巴结大分割对比常规分割一体化IMRT的多中心、随机对照III期临床研究(SHDC2020CR2052B),2020/10-2022/9,240万,结题 6、 上海市科学技术委员会2019年度“科技创新行动计划”临床医学领域,国产化同步加速器的质子治疗装置临床疗效预测评价体系及应用方案研究 (19411950900),2019.9-2022.6,200万,结题 7、 上海市促进市级医院临床技能与临床创新能力三年行动计划“重大疾病临床技能提升项目”,多学科综合治疗下乳腺癌患者心脏安全全程管理方案的III期随机对照多中心研究(16CR1037B),2016.12-2019.06,150万,结题 8、 国家自然科学基金面上项目,低剂量分次照射联合曲妥珠单抗对心脏损伤的功能和机制研究(81673102),2017/1-2020/12,55万,结题 9、 国家自然科学基金面上项目,早期乳腺癌保乳术后基于复发风险和组织病理的个体化亚临床病灶的研究(81172504),2012/01-2015/12,57万,结题 科技奖项: 2014年9月:中国抗癌学会科技奖一等奖(提高中国乳腺癌患者早期诊断率和远期生存率的临床和转化研究)(第7完成人) 申请专利 (1) 陈佳艺; 李欢; 曹璐; 易培强; 朱茜; 苏筠; 李敏 ; 用于质子水平束动物实验的固定装置, 2022-12-20, 中国, 202211639131.5 (发明专利) (2) 李欢; 曹璐; 易培强; 朱茜; 苏筠; 李敏; 陈佳艺 ; 一种用于质子水平束细胞实验的装置, 2022-12-21, 中国, 202211648568.5 (发明专利)